↑ トップへ ← 戻る

 Drug(薬物リスト) ALL | DrugBank 

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

167 / 12,172 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名(臨床試験情報から抽出)   DrugBank   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   Abatacept   Abatacept   D03203   2件: CD80, CD86   3件: Cell adhesion molecules (CAMs), Intestinal immune network for IgA production, Rheumatoid arthritis   24件:
11,
13,
19,
41,
44,
46,
49,
50,
51,
53,
55,
60,
65,
84,
93,
96,
97,
107,
164,
222,
271,
284,
285,
300 
 2   Acetate   Acetate   -   -   -   40件:
1,
2,
6,
10,
13,
35,
40,
46,
49,
51,
60,
64,
70,
71,
73,
75,
76,
78,
81,
83,
85,
86,
88,
90,
96,
97,
113,
145,
156,
162,
171,
206,
222,
224,
225,
235,
265,
288,
298,
299 
 3   Ach-0144471   -   -   -   -   3件:
62,
222,
223 
 4   Acid mycophenolic (myfortic)   -   -   -   -   1件:
222 
 5   Acth   Corticotropin   D00146   1件: MC2R   3件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Neuroactive ligand-receptor interaction   5件:
13,
66,
145,
193,
222 
 6   Acthar   Corticotropin   D00146   1件: MC2R   3件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Neuroactive ligand-receptor interaction   6件:
2,
13,
46,
49,
50,
222 
 7   Acthar 80 u 2x/week   -   -   -   -   1件:
222 
 8   Acthar 80 u 3x/week   -   -   -   -   1件:
222 
 9   Adalimumab   Adalimumab   D02597   1件: TNF   9件: Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   15件:
19,
37,
41,
46,
56,
84,
96,
97,
151,
160,
164,
222,
226,
269,
271 
 10   Adalimumab (humira)   Adalimumab   D02597   1件: TNF   9件: Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   3件:
46,
222,
271 
 11   Adrenocorticotrophic hormone acth   Corticotropin, adrenocorticotrophic hormone   D00146   1件: MC2R   3件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Neuroactive ligand-receptor interaction   1件:
222 
 12   Advagraf 0,5mg   Tacrolimus   D00107, D08556   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   1件:
222 
 13   Advagraf 1mg   Tacrolimus   D00107, D08556   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   1件:
222 
 14   Advagraf 5mg   Tacrolimus   D00107, D08556   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   1件:
222 
 15   Aldosterone   Aldosterone   D10528   1件: NR3C2   1件: Aldosterone-regulated sodium reabsorption   1件:
222 
 16   Aliskiren   Aliskiren   D03208   1件: REN   1件: Renin-angiotensin system   3件:
66,
167,
222 
 17   Amoxicillin   Amoxicillin   D00229, D02925, D07452   -   -   6件:
6,
46,
63,
96,
97,
222 
 18   Angiotensin   Angiotensin II   D00150, D02014   2件: AGTR1, AGTR2   6件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction   7件:
17,
19,
46,
66,
86,
222,
224 
 19   Angiotensin ii   Angiotensin II   D00150, D02014   2件: AGTR1, AGTR2   6件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction   2件:
66,
222 
 20   Apl-2   -   -   -   -   5件:
61,
62,
66,
222,
223 
 21   Aprovel (150 mg)   Irbesartan   D00523   1件: AGTR1   4件: Adrenergic signaling in cardiomyocytes, Neuroactive ligand-receptor interaction, Renin-angiotensin system, Vascular smooth muscle contraction   1件:
222 
 22   Aprovel 150 mg tablets   Irbesartan   D00523   1件: AGTR1   4件: Adrenergic signaling in cardiomyocytes, Neuroactive ligand-receptor interaction, Renin-angiotensin system, Vascular smooth muscle contraction   1件:
222 
 23   Atorvastatin   Atorvastatin   D00258, D00887, D07474   1件: HMGCR   1件: Terpenoid backbone biosynthesis   17件:
13,
46,
49,
51,
58,
63,
79,
84,
88,
93,
96,
160,
222,
225,
265,
271,
299 
 24   Autologous cell transplantation   -   -   -   -   1件:
222 
 25   Avacopan   Avacopan   D11093   1件: C5AR1   2件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction   4件:
43,
44,
222,
223 
 26   Bardoxolone   Bardoxolone   D09584   -   -   7件:
66,
67,
84,
85,
86,
218,
222 
 27   Bardoxolone methyl   Bardoxolone, Bardoxolone methyl   D09584, D09585   -   -   7件:
66,
67,
84,
85,
86,
218,
222 
 28   Bardoxolone methyl capsules   Bardoxolone, Bardoxolone methyl   D09584, D09585   -   -   4件:
66,
67,
86,
222 
 29   Basiliximab   Basiliximab   D03058   1件: IL2RA   4件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, JAK-STAT signaling pathway   6件:
2,
50,
65,
97,
222,
228 
 30   Belimumab   Belimumab   D03068   1件: TNFSF13B   2件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway   8件:
11,
43,
44,
46,
49,
51,
53,
222 
 31   Belimumab 10 mg   Belimumab   D03068   1件: TNFSF13B   2件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway   1件:
222 
 32   Benlysta (belimumab)   Belimumab   D03068   1件: TNFSF13B   2件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway   4件:
11,
49,
53,
222 
 33   Benlysta®   -   -   -   -   1件:
222 
 34   Benlysta® (belimumab)   Belimumab   D03068   1件: TNFSF13B   2件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway   2件:
11,
222 
 35   Bleselumab   Bleselumab   D11357   1件: CD40   4件: Allograft rejection, Cell adhesion molecules (CAMs), Cytokine-cytokine receptor interaction, Toll-like receptor signaling pathway   1件:
222 
 36   Calcium   Calcium   -   -   -   24件:
6,
13,
19,
46,
49,
51,
65,
68,
75,
79,
84,
93,
94,
95,
96,
97,
214,
215,
222,
224,
235,
265,
298,
299 
 37   Ccx140-b   -   -   -   -   1件:
222 
 38   Ccx168   -   -   -   -   6件:
43,
44,
66,
109,
222,
223 
 39   Cdx-1135   -   -   -   -   2件:
222,
223 
 40   Chlorambucil   Chlorambucil   D00266   -   -   1件:
222 
 41   Ciclofosfamida   Cyclophosphamide   D00287, D07760   -   -   1件:
222 
 42   Ciclosporin   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   13件:
26,
46,
49,
50,
53,
55,
60,
61,
97,
222,
226,
228,
269 
 43   Clarithromycin   Clarithromycin   D00276   -   -   8件:
6,
63,
84,
96,
97,
222,
228,
299 
 44   Conventional therapy   -   -   -   -   1件:
222 
 45   Corticosteroid   -   -   -   -   10件:
13,
42,
43,
44,
45,
66,
84,
96,
97,
222 
 46   Corticotropin   Corticotropin   D00146   1件: MC2R   3件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Neuroactive ligand-receptor interaction   7件:
2,
13,
46,
75,
78,
84,
222 
 47   Cxa-10   CXA-10   -   -   -   2件:
86,
222 
 48   Cyclophosphamide   Cyclophosphamide   D00287, D07760   -   -   43件:
13,
14,
16,
19,
20,
26,
28,
35,
36,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
52,
56,
60,
61,
62,
65,
66,
84,
85,
93,
96,
162,
164,
172,
222,
224,
265,
274,
283,
284,
285,
288,
326,
331 
 49   Cyclophosphamide and steroids   Cyclophosphamide   D00287, D07760   -   -   1件:
222 
 50   Cyclosporin   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   16件:
14,
38,
39,
49,
53,
56,
60,
62,
63,
97,
113,
164,
222,
223,
274,
326 
 51   Cyclosporin, low dose steroid   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   1件:
222 
 52   Cyclosporine   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   33件:
11,
14,
19,
20,
28,
36,
40,
41,
42,
45,
46,
49,
50,
53,
56,
58,
60,
62,
64,
65,
90,
95,
97,
162,
164,
222,
226,
228,
234,
283,
284,
285,
302 
 53   Cyclosporins   -   -   -   -   4件:
53,
60,
65,
222 
 54   D-galactose   Galactose   D04291   -   -   1件:
222 
 55   Dacortín 2,5mg   -   -   -   -   1件:
222 
 56   Dacortín 30mg   -   -   -   -   1件:
222 
 57   Dacortín 5mg   -   -   -   -   1件:
222 
 58   Dapagliflozin   Dapagliflozin   D08897   -   -   2件:
49,
222 
 59   Daratumumab   Daratumumab   D10777   -   -   2件:
28,
222 
 60   Dexamethasone   Dexamethasone   D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   20件:
13,
16,
28,
35,
46,
53,
63,
65,
70,
74,
75,
81,
83,
84,
90,
96,
97,
222,
296,
299 
 61   Eculizumab   Eculizumab   D03940   1件: C5   1件: Complement and coagulation cascades   7件:
11,
13,
14,
62,
109,
222,
223 
 62   Endoxan baxter*50cpr riv 50mg   -   -   -   -   1件:
222 
 63   Evolocumab   Evolocumab   D10557   1件: PCSK9   1件: Cholesterol metabolism   2件:
79,
222 
 64   Experimental (non immunosuppressive symptomatic treatment (nist) and rituximab)   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   1件:
222 
 65   Fg-3019   -   -   -   -   2件:
85,
222 
 66   Filgotinib   Filgotinib   D10871   1件: JAK1   3件: JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   6件:
46,
53,
96,
97,
222,
271 
 67   Fk506   fk506   D00107, D08556   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   2件:
86,
222 
 68   Fluvastatin   Fluvastatin   D00892, D07983   1件: HMGCR   1件: Terpenoid backbone biosynthesis   3件:
79,
218,
222 
 69   Fresolimumab   Fresolimumab   D09620   3件: TGFB1, TGFB2, TGFB3   3件: Cytokine-cytokine receptor interaction, MAPK signaling pathway, TGF-beta signaling pathway   3件:
51,
222,
274 
 70   Galactose   Galactose   D04291   -   -   2件:
171,
222 
 71   Gc1008   Fresolimumab   D09620   3件: TGFB1, TGFB2, TGFB3   3件: Cytokine-cytokine receptor interaction, MAPK signaling pathway, TGF-beta signaling pathway   2件:
85,
222 
 72   Genoxal   -   -   -   -   1件:
222 
 73   Gsk1550188   -   -   -   -   3件:
11,
49,
222 
 74   Gsk1550188 (belimumab)   Belimumab   D03068   1件: TNFSF13B   2件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway   1件:
222 
 75   H.p. acthar gel   -   -   -   -   5件:
46,
49,
50,
84,
222 
 76   Hydroxychloroquine   Hydroxychloroquine   D08050   -   -   18件:
13,
41,
46,
48,
49,
53,
56,
66,
84,
89,
90,
96,
222,
234,
254,
271,
298,
299 
 77   Inn not available yet   -   -   -   -   1件:
222 
 78   Intravenous (i.v.) methylprednisolone 1000 mg, total 9   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
222 
 79   Intravenous injection   -   -   -   -   1件:
222 
 80   Irbesartan   Irbesartan   D00523   1件: AGTR1   4件: Adrenergic signaling in cardiomyocytes, Neuroactive ligand-receptor interaction, Renin-angiotensin system, Vascular smooth muscle contraction   4件:
66,
167,
168,
222 
 81   Irbesartan tablets   Irbesartan   D00523   1件: AGTR1   4件: Adrenergic signaling in cardiomyocytes, Neuroactive ligand-receptor interaction, Renin-angiotensin system, Vascular smooth muscle contraction   2件:
66,
222 
 82   Irbesartan tablets (approved in the usa. reference listed drug avapro) ndc # 43547-0374-03   Irbesartan   D00523   1件: AGTR1   4件: Adrenergic signaling in cardiomyocytes, Neuroactive ligand-receptor interaction, Renin-angiotensin system, Vascular smooth muscle contraction   2件:
66,
222 
 83   Jianpixiaozhong particles and wuse dietotherapy   -   -   -   -   1件:
222 
 84   Lanraplenib   Lanraplenib   D11596   -   -   2件:
53,
222 
 85   Lansoprazole   Lansoprazole   D00355   2件: ATP4A, ATP4B   2件: Collecting duct acid secretion, Gastric acid secretion   6件:
63,
71,
98,
166,
222,
299 
 86   Lansoprazole, amoxicillin, clarithromycin   Amoxicillin, Clarithromycin, Lansoprazole   D00229, D00276, D00355, D02925, D07452   2件: ATP4A, ATP4B   2件: Collecting duct acid secretion, Gastric acid secretion   1件:
222 
 87   Lisinopril   Lisinopril   D00362, D08131   1件: ACE   1件: Renin-angiotensin system   5件:
46,
66,
67,
113,
222 
 88   Lisinopril, losartan, and atorvastatin   Atorvastatin, Lisinopril, Losartan   D00258, D00357, D00362, D00887, D07474, D08131, D08146   3件: ACE, AGTR1, HMGCR   5件: Adrenergic signaling in cardiomyocytes, Neuroactive ligand-receptor interaction, Renin-angiotensin system, Terpenoid backbone biosynthesis, Vascular smooth muscle contraction   1件:
222 
 89   Lnp023   -   -   -   -   3件:
62,
66,
222 
 90   Losartan   Losartan   D00357, D08146   1件: AGTR1   4件: Adrenergic signaling in cardiomyocytes, Neuroactive ligand-receptor interaction, Renin-angiotensin system, Vascular smooth muscle contraction   18件:
13,
17,
19,
46,
58,
66,
67,
85,
96,
97,
98,
113,
164,
167,
179,
215,
222,
299 
 91   Losartan tablets & qingremoshen granule   Losartan   D00357, D08146   1件: AGTR1   4件: Adrenergic signaling in cardiomyocytes, Neuroactive ligand-receptor interaction, Renin-angiotensin system, Vascular smooth muscle contraction   1件:
222 
 92   Losmapimod   Losmapimod   D09639   4件: MAPK11, MAPK12, MAPK13, MAPK14   2件: Toll-like receptor signaling pathway, VEGF signaling pathway   2件:
113,
222 
 93   Mabthera   -   -   -   -   15件:
11,
13,
35,
46,
50,
51,
53,
61,
63,
64,
65,
83,
162,
222,
271 
 94   Mabthera*ev 1fl 50ml 500mg   -   -   -   -   2件:
46,
222 
 95   Medrol   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   2件:
13,
222 
 96   Medrol*10cpr div 4mg   -   -   -   -   1件:
222 
 97   Mesenchymal stem cells   -   -   -   -   11件:
2,
6,
13,
20,
49,
51,
60,
96,
222,
274,
299 
 98   Methylprednisolon   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   4件:
13,
51,
66,
222 
 99   Methylprednisolone   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   36件:
2,
13,
25,
26,
35,
38,
39,
40,
41,
42,
43,
45,
46,
49,
50,
51,
60,
63,
64,
65,
66,
83,
84,
86,
96,
97,
145,
164,
220,
222,
224,
271,
283,
284,
285,
296 
 100   Methylprednisone   Methylprednisone   -   -   -   3件:
46,
66,
222 
 101   Mizoribine   Mizoribine   D01392   2件: IMPDH1, IMPDH2   2件: Metabolic pathways, Purine metabolism   7件:
49,
51,
53,
66,
94,
222,
224 
 102   Mmf and dexamethasone   Dexamethasone   D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
222 
 103   Mor202   -   -   -   -   1件:
222 
 104   Mp and ctx   -   -   -   -   1件:
222 
 105   Mycophenolate   Mycophenolic acid   D05096   2件: IMPDH1, IMPDH2   1件: Purine metabolism   33件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
84,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 106   Mycophenolate mofetil   Mycophenolic acid, Mycophenolate mofetil, mycophenolate mofetil   D00752, D05094, D05095, D05096   2件: IMPDH1, IMPDH2   1件: Purine metabolism   32件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 107   Mycophenolate mofetil (mmf)   Mycophenolic acid, Mycophenolate mofetil, mycophenolate mofetil   D00752, D05094, D05095, D05096   2件: IMPDH1, IMPDH2   1件: Purine metabolism   4件:
49,
60,
66,
222 
 108   Mycophenolate mofetil orally 1000 mg twice a day (bid)   Mycophenolic acid, Mycophenolate mofetil, mycophenolate mofetil   D00752, D05094, D05095, D05096   2件: IMPDH1, IMPDH2   1件: Purine metabolism   1件:
222 
 109   Mycophenolate mofetil, low dose steroid   Mycophenolic acid, Mycophenolate mofetil, mycophenolate mofetil   D00752, D05094, D05095, D05096   2件: IMPDH1, IMPDH2   1件: Purine metabolism   1件:
222 
 110   Mycophenolate sodium   Mycophenolic acid, mycophenolate sodium   D05096   2件: IMPDH1, IMPDH2   1件: Purine metabolism   3件:
53,
66,
222 
 111   Mycophenolic acid   Mycophenolic acid   D05096   2件: IMPDH1, IMPDH2   1件: Purine metabolism   7件:
11,
49,
51,
60,
66,
96,
222 
 112   Mycophenolic sodium   -   -   -   -   2件:
66,
222 
 113   Myfortic   Mycophenolic acid   D05096   2件: IMPDH1, IMPDH2   1件: Purine metabolism   4件:
49,
66,
222,
228 
 114   Myfortic 180mg tablets   Mycophenolic acid   D05096   2件: IMPDH1, IMPDH2   1件: Purine metabolism   2件:
66,
222 
 115   Myfortic 360mg tablets   Mycophenolic acid   D05096   2件: IMPDH1, IMPDH2   1件: Purine metabolism   2件:
66,
222 
 116   Myfortic plus low-dose steroid   -   -   -   -   1件:
222 
 117   Neoral   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   2件:
97,
222 
 118   Oms721   -   -   -   -   5件:
64,
66,
109,
222,
223 
 119   Oral cyclosporine   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   1件:
222 
 120   Over-encapsulated 75 mg irbesartan tablets   Irbesartan   D00523   1件: AGTR1   4件: Adrenergic signaling in cardiomyocytes, Neuroactive ligand-receptor interaction, Renin-angiotensin system, Vascular smooth muscle contraction   1件:
222 
 121   Over-encapsulated irbesartan tablets   Irbesartan   D00523   1件: AGTR1   4件: Adrenergic signaling in cardiomyocytes, Neuroactive ligand-receptor interaction, Renin-angiotensin system, Vascular smooth muscle contraction   2件:
66,
222 
 122   Pentoxifylline   Pentoxifylline   D00501   -   -   10件:
26,
56,
84,
93,
96,
113,
220,
222,
296,
298 
 123   Perindopril   Perindopril   D00624, D03753   1件: ACE   2件: Renin secretion, Renin-angiotensin system   2件:
167,
222 
 124   Pf-06730512   -   -   -   -   1件:
222 
 125   Pirfenidone   Pirfenidone   D01583   6件: CCL2, IL10, IL1A, IL1B, IL6, TNF   5件: Cellular senescence, Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, TGF-beta signaling pathway, TNF signaling pathway   10件:
34,
46,
50,
51,
58,
84,
85,
164,
222,
228 
 126   Prednisolone   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   38件:
11,
13,
25,
26,
35,
38,
39,
41,
43,
44,
45,
46,
49,
50,
51,
56,
60,
61,
63,
64,
65,
66,
75,
81,
84,
85,
95,
96,
97,
113,
145,
162,
222,
269,
271,
296,
299,
300 
 127   Prednisolone acetate   Acetate, Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
222 
 128   Prednisolone and chlorambucil   Chlorambucil, Prednisolone   D00266, D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
222 
 129   Prednisolone and mycophenolate mofetil   Mycophenolic acid, Mycophenolate mofetil, Prednisolone, mycophenolate mofetil   D00472, D00752, D00980, D00981, D00982, D01239, D01998, D02156, D03301, D05094, D05095, D05096   3件: IMPDH1, IMPDH2, NR3C1   2件: Neuroactive ligand-receptor interaction, Purine metabolism   1件:
222 
 130   Prednisona   Prednisone   D00068, D02798, D04855, D06542   -   -   2件:
49,
222 
 131   Prednisone   Ethanol   D00068, D02798, D04855, D06542   -   -   43件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
61,
63,
64,
65,
66,
81,
84,
85,
86,
95,
96,
97,
113,
162,
164,
222,
224,
228,
251,
283,
284,
285,
288,
299,
300,
331 
 132   Prednisone 0,5 mg/kg orally on alternate days   Ethanol   D00068, D02798, D04855, D06542   -   -   1件:
222 
 133   Prednisone, fk506, mmf   Ethanol   D00068, D02798, D04855, D06542   -   -   1件:
222 
 134   Prograf   Tacrolimus   D00107, D08556   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   3件:
60,
222,
226 
 135   Propagermanium   -   -   -   -   1件:
222 
 136   Re-021   -   -   -   -   2件:
66,
222 
 137   Re-021 (sparsentan)   Sparsentan   -   -   -   1件:
222 
 138   Repository corticotropin injection   Corticotropin   D00146   1件: MC2R   3件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Neuroactive ligand-receptor interaction   5件:
2,
13,
46,
84,
222 
 139   Rituximab   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   42件:
11,
13,
14,
17,
35,
36,
43,
44,
45,
46,
49,
50,
51,
52,
53,
56,
60,
61,
63,
64,
65,
66,
83,
84,
85,
86,
93,
94,
96,
97,
162,
222,
223,
229,
256,
271,
283,
284,
285,
288,
300,
331 
 140   Rituximab infusion   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   2件:
13,
222 
 141   Rosiglitazone   Rosiglitazone   D00596, D08491   1件: PPARG   2件: AMPK signaling pathway, PPAR signaling pathway   5件:
46,
75,
97,
222,
265 
 142   Rosiglitazone (avandia)   Rosiglitazone   D00596, D08491   1件: PPARG   2件: AMPK signaling pathway, PPAR signaling pathway   1件:
222 
 143   Sirolimus   Sirolimus   D00753   1件: MTOR   2件: Pathways in cancer, mTOR signaling pathway   30件:
13,
17,
34,
35,
36,
46,
51,
60,
62,
63,
65,
66,
67,
85,
89,
96,
98,
137,
157,
158,
192,
222,
277,
278,
279,
280,
281,
283,
285,
331 
 144   Soliris   Eculizumab   D03940   1件: C5   1件: Complement and coagulation cascades   7件:
11,
13,
14,
62,
109,
222,
223 
 145   Solondo   -   -   -   -   1件:
222 
 146   Sparsentan   Sparsentan   -   -   -   2件:
66,
222 
 147   Steroid & cyclosporin   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   1件:
222 
 148   Sulfate   Sulfate ion   -   -   -   22件:
2,
6,
11,
13,
26,
34,
36,
46,
49,
60,
61,
64,
66,
79,
86,
96,
222,
226,
265,
296,
297,
299 
 149   Symptomatic treatment (converting enzyme inhibitor, angiotensin ii, anti-renin, aldosterone antagonist diuretic, beta blocker, calcium inhibitor, statin)   Aldosterone, Angiotensin II, Calcium   D00150, D02014, D10528   3件: AGTR1, AGTR2, NR3C2   7件: Adrenergic signaling in cardiomyocytes, Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction   1件:
222 
 150   Synacthen depot 1mg   -   -   -   -   1件:
222 
 151   Tacrolimus   Tacrolimus   D00107, D08556   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   29件:
2,
11,
13,
36,
46,
49,
50,
51,
53,
60,
61,
62,
65,
66,
85,
95,
96,
97,
113,
151,
158,
164,
222,
224,
226,
228,
283,
284,
299 
 152   Tacrolimus capsules   Tacrolimus   D00107, D08556   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   2件:
222,
299 
 153   Tacrolimus combined with prednisone   Ethanol, Tacrolimus   D00068, D00107, D02798, D04855, D06542, D08556   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   1件:
222 
 154   Tetracosactide   Tetracosactide   D00284   1件: MC2R   3件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Neuroactive ligand-receptor interaction   4件:
83,
113,
145,
222 
 155   Tetracosactide hexacetaat   Tetracosactide   D00284   1件: MC2R   3件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Neuroactive ligand-receptor interaction   1件:
222 
 156   The comprehensive treatment regimen of traditional chinese medicine   -   -   -   -   1件:
222 
 157   The immunosuppressive agents   -   -   -   -   1件:
222 
 158   Tripterygium   Tripterygium wilfordii whole   -   -   -   8件:
46,
66,
67,
96,
162,
222,
224,
271 
 159   Tripterygium wilfordii   Tripterygium wilfordii whole   -   -   -   6件:
46,
66,
67,
222,
224,
271 
 160   Tripterygium wilfordii (tw)   Tripterygium wilfordii whole   -   -   -   2件:
66,
222 
 161   Tru-015   TRU-015   -   -   -   3件:
46,
49,
222 
 162   Urbason*im ev 1f 250mg+1f 5ml   -   -   -   -   1件:
222 
 163   Valproic acid   Valproic Acid   D00399   6件: ABAT, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2   2件: Calcium signaling pathway, GABAergic synapse   10件:
3,
5,
26,
34,
65,
89,
90,
222,
256,
331 
 164   Valsartan   Valsartan   D00400   1件: AGTR1   4件: Adrenergic signaling in cardiomyocytes, Neuroactive ligand-receptor interaction, Renin-angiotensin system, Vascular smooth muscle contraction   6件:
57,
58,
66,
75,
218,
222 
 165   Vitamin d   Vitamin D   -   -   -   18件:
13,
19,
41,
46,
49,
50,
68,
93,
95,
96,
98,
179,
222,
228,
235,
274,
298,
299 
 166   Voclosporin   Voclosporin   D09033   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   1件:
222 
 167   Zestril   Lisinopril   D00362, D08131   1件: ACE   1件: Renin-angiotensin system   2件:
67,
222 

先頭へ